Kain Capital is backing a network of 26 imaging centers across Florida, Michigan, Maryland, Georgia, Tennessee and Alabama, co-founded by radiologist Chintan Desai, MD.
The Los Angeles-based imaging center operator will use the proceeds to finance future acquisitions, “organic expansion initiatives,” and health system partnerships.
It was once a given that hospital chief financial officers would be first in line to fill CFO positions in multi-hospital health systems when those bigger jobs opened up. That’s no longer necessarily the case, according to a new report on the current state and unfolding future of the role.
A PET exam depicting whole-body imaging of traveling blood clots has been named the Society of Nuclear Medicine and Molecular Imaging’s Henry N. Wagner Jr. Image of the Year.
AI shines as a first reader for ruling out suspicious findings in breast cancer screening exams, a new analysis in Radiology: Artificial Intelligence reveals.
Abbott's TAVR valve now has CE mark approval for treating low-, intermediate- and high-risk patients who present with symptomatic severe aortic stenosis. The news comes as new data on the valve's safety and effectiveness were just published in JACC: Cardiovascular Interventions.
Recor Medical's Paradise Ultrasound Renal Denervation System is the first medical device approved for the treatment of hypertension in Japan. It first gained FDA approval back in 2023.
Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%.
Kain Capital is backing a network of 26 imaging centers across Florida, Michigan, Maryland, Georgia, Tennessee and Alabama, co-founded by radiologist Chintan Desai, MD.
The Los Angeles-based imaging center operator will use the proceeds to finance future acquisitions, “organic expansion initiatives,” and health system partnerships.
